engleski

Out-of-field dose measurements in radiotherapy – An overview of activity of EURADOS Working Group 9: Radiation Protection in Medicine

This review of dosimetry for second cancer risk estimation introduces work carried out by Working Group 9 (WG9: Radiation Protection Dosimetry in Medicine) of the European Radiation Dosimetry Group (EURADOS). The work concentrates on the measurement of out-of-field doses in water phantoms using a variety of dosimeters to measure photon and neutron doses. These include optically stimulated luminescence (OSL), radiophotoluminescence (RPL) and thermoluminescence (TLD) dosimeters for photon dosimetry (together with ion chambers for reference measurements) and track etch and superheated emulsion detectors for neutron measurements. The motivation of WG 9 was to assess undue, non-target patient doses in radiotherapy and the related risks of second malignancy. Improvements in cancer treatment have increased survival times and thus increased incidence of second cancer may be expected in the future. In addition, increased whole body exposure may result from some developments in radiotherapy. This means that radiotherapy clinics will need to simulate their treatments in order to estimate and minimize doses to healthy tissues and organs. The proposed work is designed to generate a robust dataset of out-of-field dose measurements which can be used for the development and validation of dose algorithms.

Out-of-field doses in radiotherapy; RPL; TLD; OSL; Superheated emulsion detectors; Track etch PADC detectors; IMRT; VMAT; Tomotherapy

Rad je prezentiran na skupu The 17th Solid State Dosimetry Conference (SSD17).